These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 284362)

  • 1. Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
    Dale GL; Kuhl W; Beutler E
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):473-5. PubMed ID: 284362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.
    Belchetz PE; Crawley JC; Braidman IP; Gregoriadis G
    Lancet; 1977 Jul; 2(8029):116-7. PubMed ID: 69198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry.
    Willemsen R; van Dongen JM; Ginns EI; Sips HJ; Schram AW; Tager JM; Barranger JA; Reuser AJ
    J Neurol; 1987 Jan; 234(1):44-51. PubMed ID: 3819786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
    Beutler E; Dale GL
    Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiglucerase and its use for the treatment of Gaucher's disease.
    Weinreb NJ
    Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E; Dale GL; Guinto DE; Kuhl W
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4620-3. PubMed ID: 200923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian glucocerebrosidase: implications for Gaucher's disease.
    Glew RH; Basu A; LaMarco KL; Prence EM
    Lab Invest; 1988 Jan; 58(1):5-25. PubMed ID: 3275832
    [No Abstract]   [Full Text] [Related]  

  • 9. Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease.
    Lonser RR; Walbridge S; Murray GJ; Aizenberg MR; Vortmeyer AO; Aerts JM; Brady RO; Oldfield EH
    Ann Neurol; 2005 Apr; 57(4):542-8. PubMed ID: 15786474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 11. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
    Niederau C; Holderer A; Heintges T; Strohmeyer G
    J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
    Furbish FS; Blair HE; Shiloach J; Pentchev PG; Brady RO
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3560-3. PubMed ID: 269414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.
    Korablyov V; Zimran A; Barenholz Y
    Pharm Res; 1999 Mar; 16(3):466-9. PubMed ID: 10213382
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired Gaucher's cells in Hodgkin's disease.
    Lee KS; Tobin MS; Chen KT; Ahmed F; Gomez-Leon G
    Am J Med; 1982 Aug; 73(2):290-4. PubMed ID: 7114083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.
    Shaaltiel Y; Gingis-Velitski S; Tzaban S; Fiks N; Tekoah Y; Aviezer D
    Plant Biotechnol J; 2015 Oct; 13(8):1033-40. PubMed ID: 25828481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher's disease in the presence of normal glucocerebrosidase activity.
    Schofield DE; Scott CR; Lage JM; Farrell DF
    Hum Pathol; 1992 May; 23(5):588-92. PubMed ID: 1568755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.